Science Explorer Interactive view Map

Novavax (United States)

Research works
110
▲ 45% vs 2013–17
Citations
4.3k
39.1 per fractional work
Top-10% rate
34.5%
record average 16.5%
Open access
82%
world 28%

Not ranked overall: Novavax (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.03× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.03× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 9.75× its world share, 5 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.34× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.14× its world share, 1 worksChemistryComputer Science: 0.14× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringMathematics: 1.97× its world share, 1 worksMathematicsHealth Professions: 0.32× its world share, 0 worksHealth ProfessionsMedicine: 2.99× its world share, 27 worksMedicineVeterinary: 2.64× its world share, 0 worksVeterinaryDecision Sciences: 0.19× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.18× its world share, 0 worksEconomics, Econometr…Psychology: 0.26× its world share, 0 worksPsychologySocial Sciences: 0.66× its world share, 4 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 9.8×. Every wedge is a field page.

Who are the top researchers at Novavax (United States)?

Ranked on the composite score, Gale Smith and Louis Fries lead among researchers whose main affiliation is Novavax (United States).

  1. 1 Gale Smith United States · #375,353 worldwide 150 citations · 19 works
  2. 2 Louis Fries United States · #590,132 worldwide 95 citations · 17 works
All ranked researchers at Novavax (United States)

Which keywords describe research at Novavax (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Pandemic, SARS-CoV-2, Vaccine, ACE2 Receptor, Coronavirus, Epidemiology, Immunity and Viral Transmission.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Pandemic16▲ 32×5 topics
  2. SARS-CoV-215▲ 102×6 topics
  3. Vaccine14▲ 75×8 topics
  4. ACE2 Receptor14▲ 122×2 topics
  5. Epidemiology13▲ 7.0×20 topics
  6. Coronavirus13▲ 129×3 topics
  7. Immunity12▲ 65×3 topics
  8. Viral Transmission11▲ 154×2 topics
  9. antibody10▲ 210×1 topic
  10. spike protein10▲ 210×1 topic
  11. Immune Response7▲ 26×7 topics
  12. Pathogenesis6▲ 24×10 topics
  13. Antigen Presentation5▲ 114×2 topics
  14. Health Behavior4▲ 88×2 topics
  15. COVID-19 Vaccine4▲ 113×1 topic
  16. Thrombosis4▲ 29×2 topics
  17. Vaccine Hesitancy4▲ 123×1 topic
  18. Epitope Prediction4▲ 288×1 topic
  19. Peptide-MHC Binding4▲ 288×1 topic
  20. Clinical Characteristics3▲ 58×1 topic
  21. Cytokine Storm3▲ 68×1 topic
  22. COVID-193▲ 4.7×8 topics
  23. Circovirus2▲ 145×1 topic
  24. Infectious Diseases2▲ 14×2 topics
  25. Porcine Reproductive and Respiratory Syndrome Virus2▲ 145×1 topic
  26. Genomics2▲ 13×2 topics
  27. Influenza2▲ 89×1 topic
  28. Vaccine Development2▲ 14×3 topics
  29. Virus2▲ 39×1 topic
  30. Human Metapneumovirus2▲ 73×1 topic
  31. Innate Immunity2▲ 10×3 topics
  32. Respiratory Syncytial Virus2▲ 73×1 topic
  33. Monoclonal Antibodies1▲ 30×3 topics
  34. Epigenetic Reprogramming1▲ 28×2 topics
  35. Therapeutic Antibodies1▲ 38×2 topics
  36. Cancer Immunotherapy1▲ 16×1 topic
  37. Dendritic Cells1▲ 27×1 topic
  38. Innate Memory1▲ 109×1 topic
  39. Trained Immunity1▲ 109×1 topic
  40. Pattern Recognition Receptors1▲ 17×2 topics

Which research topics does Novavax (United States) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, vaccines and immunoinformatics approaches and COVID-19 Clinical Research Studies.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 10 works
  2. 2 Vaccine Coverage and Hesitancy Health 4 works
  3. 3 vaccines and immunoinformatics approaches Molecular Biology 4 works
  4. 4 COVID-19 Clinical Research Studies Infectious Diseases 3 works
  5. 5 Animal Virus Infections Studies Animal Science and Zoology 2 works
  6. 6 Influenza Virus Research Studies Epidemiology 2 works
  7. 7 Respiratory viral infections research Epidemiology 2 works
  8. 8 Immunotherapy and Immune Responses Immunology 1 works
  9. 9 Immune responses and vaccinations Immunology 1 works
  10. 10 COVID-19 epidemiological studies Modeling and Simulation 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.9%not open18.1%

World: 28% of research is openly available.

with international co-authors18.6%domestic only81.4%

World: 19% is written across borders.

How has Novavax (United States)'s research output changed?

Output in 2018–2022 was 45% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.